Previous 10 | Next 10 |
TherapeuticsMD (NASDAQ: TXMD ) and TPG Sixth Street Partners have amended the terms of the Company’s existing term loan financing facility to revise the draw trigger for one of the two $50M delayed draw loan tranches. More news on: TherapeuticsMD, Inc., Healthcare stocks news, ...
- Amendment revises draw trigger for $50 million loan tranche previously tied to ANNOVERA TM designation - TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that the Company and TPG Sixth Street Partners (“Sixth Street&...
This article was selected to be shared with PRO+ Short Ideas subscribers - find out more here . As the stock market is reaching new highs, it is becoming more challenging to find fundamentally strong buys that are reasonably valued. However, there are some extremely overvalued stocks with...
Bausch Health Companies (NYSE: BHC ) initiated with Neutral rating and C$40 (7% upside) price target at Goldman Sachs. Shares up 2% premarket. More news on: Bausch Health Companies Inc., Centogene N.V., Galapagos NV, Healthcare stocks news, Stocks on the move, , Read more ....
Knight Therapeutics' ( OTC:KHTRF ) New Drug Submission (NDS) for BIJUVA has been accepted for review by Health Canada. More news on: Knight Therapeutics Inc., TherapeuticsMD, Inc., Healthcare stocks news, Read more ...
Knight Therapeutics Inc. (TSX: GUD) (“Knight”) and TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD”) announced today that Knight's New Drug Submission (NDS) for BIJUVA ® has been accepted for review by Health Canada. BIJUVA, estradiol and progesterone ca...
The following slide deck was published by TherapeuticsMD, Inc. in conjunction with this Read more ...
TherapeuticsMD ( TXMD ) reported a strong third quarter with net revenues that came in at the upper end of TherapeuticsMD Q3 guidance. The company's FDA approved products demonstrated impressive numbers in both sales and script growth, which demonstrates the company's ability to simultaneous...
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate in the Stifel 2019 Healthcare Conference in New York City. Chief Executive Officer Robert G. Finizio will provide an overview of the company at the conferenc...
Gainers: DRTT +7.9% . EGO +3.2% . AU +1.9% . OBSV +1.7% . More news on: Eldorado Gold Corporation, AngloGold Ashanti Limited, ObsEva SA, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...